Overview Performance Dividends Peer Group Options

ZEAL Dividend History & Analysis | 100% Free Data

ZEAL's dividend history, current yield (0%), dividend growth rate (N/A), complete payout history and peer comparison (Biotechnology).

As of July 2025, Zealand Pharma (ZEAL) does not pay a dividend.

Top Dividend Payers in Biotechnology

Top 5 Dividend Yields of Peer-Group
Symbol Market Cap (USD) Dividend Yield TTM Yield on Cost (purchase 5y ago)
ORKA 888 M 129% 37.5%
ABBV 352,363 M 3.43% 7.95%
GILD 142,480 M 3.10% 4.88%
AMGN 163,608 M 3.12% 4.15%
NOVO-B 298,284 M 2.18% 5.50%
Top 5 Dividend Growth Rates of Peer-Group
Symbol Market Cap (USD) Growth Rate (5y CAGR) Payout Consistency
BIM 16,328 M 34.9% 95.8%
BIOG-B 1,106 M 20.4% 95.9%
NOVO-B 298,284 M 18.2% 88.5%
SECARE 731 M 10.4% 100%
HLN 45,450 M 22.9% 100%

Similar Stocks with Attractive Dividends

ABBV
AbbVie
 3.43% Yield
VOX
Voxel S.A.
 1.75% Yield
AMGN
Amgen
 3.12% Yield
NOVO-B
Novo Nordisk
 2.18% Yield
GILD
Gilead Sciences
 3.10% Yield

ZEAL Dividend History: as of July 2025

No dividends paid yet.

ZEAL Dividend FAQ

Does ZEAL pay a dividend?

As of July 2025 ZEAL does not pay a dividend.

What is the Dividend Yield of ZEAL?

As of July 2025, ZEAL`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 359.20.

How often does ZEAL pay dividends?

Over the last 12 months, ZEAL has issued dividend payments.

Will ZEAL pay dividends in 2025?

The next Ex-Dividend date for Zealand Pharma (ZEAL) is currently unknown.

What is the next Ex-Dividend Date for ZEAL?

The next Ex-Dividend date for Zealand Pharma (ZEAL) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.

What is the Dividend Growth of ZEAL?

ZEAL's average dividend growth rate over the past 5 years is -% per year.

What is the Yield on Cost of ZEAL?

ZEAL's 5-Year Yield on Cost is -%. If you bought ZEAL's shares at 236.20 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.

What is the Payout Consistency of ZEAL?

ZEAL Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.

Does ZEAL have a good Dividend Yield?

ZEAL`s 0.00% Dividend Yield is considered as unknown.

What is the Dividend Payout Ratio of ZEAL?

The Dividend Payout Ratio of ZEAL is unknown.

What is the Dividend Rating of ZEAL?

ZEAL`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.

ZEAL Outstanding Shares Analysis

What is the Trend in ZEAL`s Outstanding Shares?

Zealand Pharma`s outstanding shares have increased by approximately 10.89% annually over the past 5 years (Correlation: 100.0%), negatively influencing the share price.

Has Zealand Pharma ever had a Stock Split?

No Stock Splits found.
Year Number of Shares Annual Growth Rate
2010 22,870,500
2011 22,807,600 -0.28%
2012 22,658,900 -0.65%
2013 25,531,000 +12.68%
2014 22,672,700 -11.2%
2015 23,866,200 +5.26%
2016 25,579,100 +7.18%
2017 30,751,300 +20.22%
2018 30,843,300 +0.3%
2019 36,051,400 +16.89%
2020 42,152,000 +16.92%
2021 43,634,400 +3.52%
2022 49,810,400 +14.15%
2023 58,378,000 +17.2%
2024 70,662,100 +21.04%

Key Metric Definitions

  • Dividend Yield: Annual dividend per share divided by current share price.
  • Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
  • Payout Ratio: Percentage of earnings paid as dividends (TTM).
  • Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
  • Payout Frequency: Number of dividends paid per year (typically quarterly).
  • Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
  • Total Return: Price appreciation plus dividends over specified period.
  • Market Cap: Figures are in millions of the corresponding currency.